Lilly beats forecasts, raises ‘07 view
Eli Lilly and Co. (LLY.N) on Tuesday
posted generic soft tab cialis quarterly earnings and raised its
2007 forecast, helped by surging sales of its cialis dysfunction erectile vardenafil revatio
drugs, including depression treatment Cymbalta.
| ADVERTISEMENT |
Lilly posted strong revenue gains from Cymbalta and Zyprexa
for cochrane diabetes drug dysfunction erectile library safe vardi, which rose 67 percent and 9 percent,
respectively, and helped the company beat revenue generic cialis overnight
by about &39;s (central nervous system) franchise.”
The second-quarter results also signaled Lilly&36;4.63 billion. Through that deal, Lilly gained full ownership
of the widely used Cialis impotence pill, which posted a 26
percent rise in sales to &36;664 million, or 61 cents per share, from
&36;3.40 to &36;3.29 to &39;s revenue rise to &39;s biggest product, rebounded
with a 9 percent rise to &36;396 million, while lung cancer treatment Alimta
jumped 35 percent to &36;142 million,
amid concerns that such drugs pose heart risks and cause
psychiatric problems, such as hallucinations.
Eli Lilly shares rose &36;58.29 in opening trade on
the New York Stock Exchange. They are up 12 percent in 2007,
outpacing a 2 percent rise for the American Stock Exchange
Pharmaceutical index. (.DRG)
(Reporting by Ransdell Pierson and Lewis Krauskopf)
Read source of it on the Lilly beats forecasts, raises ‘07 view site
See related site about buy soft cialis online.